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Contact Lens Care Solutions and 
Ocular Surface
José Manuel González Méijome
SUMMARY
Safe wear of non-daily disposable contact lenses require care systems 
to ensure disinfection and cleaning to allow the lens to be reused after 
a period of non lens wear (typically overnight). To do so, modern care 
systems, also known as multipurpose solutions (MPS) or multipurpose 
disinfecting solutions (MPDS) try to mimic the environment of the 
ocular surface regarding pH, osmolality, surface tension or viscosity 
while introducing other singular properties as a wide-spectrum 
antimicrobial activity and high cleaning performance. This delicate 
equilibrium or properties is challenging and sometimes results in 
adverse events that have drawn the attention of the CL industry and 
scientifi c community to these systems with an increased intensity 
during the past decade. 
Even with disposable lenses, safety is still a concern and presently we 
are in front of a new paradigm of solutions development, which must 
provide reinforced disinfecting capabilities and at the same time improve 
the compatibility with the ocular surface. Indeed, disinfection effi cacy 
against different new strains of microorganisms and compatibility with 
the ocular surface have been two aspects widely covered in the recent 
scientifi c literature, topics that will also be addressed in this chapter.
INTRODUCTION
Care solutions are essential for contact lens (CL) safety and durability. They 
were fi rst intended for cleaning and disinfecting lenses for non-planned 
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replacement lenses, commonly using products with poor compatibility 
with the ocular surface, such as hydrogen peroxide, chlorhexidine or 
benzalconium chloride. In spite of their effi cacy against microorganisms, 
they were somewhat inconvenient, at least in their earlier formulations 
particularly when used with hydrophilic lenses that absorb such components 
into their matrix. 
Care systems were initially complex in the sense that the wearer must 
use different products; nowadays the care systems have evolved into 
complex formulations that meet all the requirements for a care system in a 
single package in order to make its use easier and more convenient to the CL 
wearer and improve compliance. However, this combination of properties 
into the same package requires an optimal balance between the disinfecting 
and cleaning activity and the respect for the ocular surface homeostasis.
Today, development of effective care systems is a challenging task once 
they have to be effective for cleaning and disinfection, and at the same time 
respect the physiology of the ocular surface, be convenient for the wearer 
and when possible and improve the comfort of the CL during the whole 
day. These are the requirements for current MPDS that represent over 80% 
of the all care systems prescribed (Morgan et al. 2010). With the advent of 
disposable CL cleaning capability has become less important and industry 
makes efforts to provide MPDS with new features that address one of the 
main unsolved issues for contact lens wearers: all day comfortable wear. 
As a result, current MPDS are the result of complex chemical and biological 
engineering that must have a critical combination of properties such as 
pH, osmolality, viscosity maintaining high standards of disinfection and 
cleaning effi cacy.
REQUIREMENTS AND COMPOSITION OF CURRENT 
CARE SOLUTIONS
The basic requirements for a CL care system are to clean tear and 
environmental products deposited every day on the surface of the lens, to 
remove the materials that had been strongly adhered to the CL material, 
to disinfect the lens by reducing the populations of microorganisms to 
safety levels, to warrant that the CL material remains fully hydrated, and 
desirably, to improve the CL wetting properties to extend wearing comfort 
during the whole day of wearing. 
Table 1 shows some examples of soft CL MPS marketed and their 
composition. Composition of MPDS is critical because of the potential 
impact on the interaction with the contact lenses and with the ocular surface. 
Similar compositions can be described for rigid gas permeable lenses (RGP). 
Eventually, in the case of RGP materials, due to their inability to absorb 
the active ingredients, other preservative or biocidal agents as derivates or 
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chlorhexidine or even benzalkonium chloride (BAK), no longer incorporated 
to soft CL care systems, can be used. Other major difference with soft CL 
systems is that such MPDS use to have higher viscosity to improve the 
comfort of the CL by increasing the wetting capabilities of the surface and 
cushioning the contact between the RGP CL and the ocular surface.
PROPERTIES OF CARE SYSTEMS
Considering the intimal relationship of care solutions with the contact lens 
material and the ocular surface, the properties of the care systems are critical 
for a good performance. 
Some of the most relevant properties include: pH, osmolality, surface 
tension, and viscosity. The relevance of these properties, from the clinical 
point of view range from the impact on insertion comfort to the dynamic 
interaction of the lens with the ocular surface (cornea, bulbar conjunctiva 
and tarsal conjunctiva). In brief, a solution with pH or osmolality out of 
the physiological range (Table 2), could result in discomfort at insertion; an 
excessive surface tension will result in decreased spread of the solution over 
the CL or the ocular surface; too low viscosity will decrease the lubricating 
effect of the tears in the interaction of the lens with the ocular surface; too 
high viscosity will result in an improved lubricating effect but eventually 
could result in poor visual due to irregularities in the tear fi lm or even lens 
binding to the surface. Dalton et al. evaluated these properties in 10 care 
systems including 7 MPS solutions and 3 neutralized hydrogen peroxide 
solutions (Dalton et al. 2008). The main results of this study are summarized 
in Table 2 along with the normal range for the normal tears. 
Although the normal pH of tears has been defi ned between 6.2 and 9.0, 
care systems must be formulated to maintain the pH between 6.6 and 7.8, 
which is also known as the comfort zone (Carney and Hill 1976). As seen 
in table 2, most of the solutions do respect these desired limits, although 
presenting signifi cant differences among them. 
Beyond their intrinsic properties, it is also interesting to evaluate the 
potential changes of such parameters overtime. Previous studies have 
demonstrated that properties such as pH can remain within the normal 
physiological range during a signifi cant period of time in spite of some 
fl uctuations (Lopez-Alemany and Montes 1998). Recent studies have 
addressed the changes in pH and osmolality over a month for different 
products and particularly when the lens cases are subjected to different 
cleaning, rinsing and drying procedures (Abengozar-Vela et al. 2011). Some 
cleaning and drying procedures of the storage lens cases can affect properties 
such as osmolality (Abengozar-Vela et al. 2011) such that air-drying, today 
recommended by several manufacturers, can increase signifi cantly the 
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osmolality of the solution where the lenses are immersed overnight if a 
tissue-wiping step is not added to the process.
DISINFECTING EFFICACY
Disinfecting effi cacy of CL care systems is another critical property and it 
is measured as the reduction of viable organisms or colony forming units 
(CFU’s) during the recommended disinfection time or during a certain period 
of time as set by FDA and ISO standards. The usual number of organisms 
inoculated is in the order of 106 units or CFU’s. Typically, a care system 
should be challenged against several organisms, including gram-negative 
and gram-positive bacteria, mold and yeast. The results are expressed in 
terms of logarithm units of reduction such that 1 log unit corresponds to the 
elimination or neutralization of 90% of the organisms initially inoculated 
(105 CFU’s remaining); similarly 2 log units are equivalent to a double 
reduction of 90% (104 CFU’s remaining), etc. After a 5 log reduction, only 
10 CFU’s will remain and after a 6 log reduction, only 1 CFU will remain. 
Standards require at least a 3 log reduction for bacteria (gram-positive and 
gram-negative) and 1 log reduction for mold and yeast.
Figure 1 represents the requirements set by FDA and ISO required 
for a given care system although these regulations are under review to 
incorporate more microorganisms. 
Nowadays, most CL care systems and particularly those new systems 
being developed are being challenged against a much wider spectrum 
of microorganisms, including those responsible for serious public health 
concerns as antibiotic-resistance microorganisms and clinical isolates 
*hydrogen peroxide in its neutral form.
Care System pH Osmolality 
(mOsm/Kg)
Surface Tension 
(mN/m)
Viscosity 
(cP @ 34ºC)
Average for Tears 6.2–9.0 305 40–46 1.5–5.0
Soft Wear Saline 6.97 303.5 67.9 0.70
Solo Care Aqua 7.23 310 35.1 0.81
Sensitive Eyes MPS 7.29 286.7 38.0 0.83
ReNu MultiPlus 7.38 286.2 36.3 0.84
Complete Moisture Plus 7.28 304.3 40.5 1.92
Opti-Free RepleniSH 7.88 277.2 29.7 0.71
Opti-Free Express 7.82 225.0 31.2 0.76
Clear Care* 6.76 293.7 42.9 0.69
AOSept* 6.66 290.7 70.3 0.69
Ultracare* 7.18 329.0 43.2 0.86
Table 2 This table summarizes the results of Dalton et al. regarding the physical and chemical 
properties of different contact lens care systems (Dalton et al. 2008).
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(extracted from contaminated cases or infected eyes instead of using only 
strains from laboratory cultures) in order to provide stronger evidences of 
the effi cacy of the MPDS against “real world microorganisms”. This has 
been the case in a study published by Zhu et al. (Zhu et al. 2007) where 
up to 10 gram-positive bacteria, 8 gram-negative bacteria and 3 fungi (2 
yeast and 1 mold) were evaluated. Other study conducted by Kilvington 
et al. (Kilvington et al. 2010) on a new MPDS also evaluated different 
microorganisms from those recommended by FDA and ISO standards. 
Acanthamoeba castellanii, one of the most virulent and challenging ocular 
microorganism, either in the trophozoite and cyst forms were evaluated, 
providing quite different results among different solutions, particularly 
in the cystic form where some solutions were ineffective to achieve a 3 
log reduction; such results reinforce the need for tighter standards for 
MPDS evaluation. Further, these authors evaluated the effi cacy of different 
solutions after evaporation of the solution, a condition that could derive 
from poor compliance from the patient and that could act as a risk factor 
for ocular infection due to reduced biocidal activity of the solution and/or 
to increased resistance of the microorganisms in such environment.
INTERACTIONS OF CARE SYSTEMS WITH THE 
OCULAR SURFACE
The components of the CL solutions can be related to several adverse 
reactions in the ocular surface by mediating a toxic reaction due to prolonged 
Figure 1 Standards of reduction in CFU viability and performance of a given MPDS against 
gram-positive and gram-negative bacteria, yeast and mold.
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contact once the products adhered to the lens material leak to the ocular 
surface. Several studies have tried to relate these clinical events presenting 
in the form of ocular surface damage to the presence of certain components 
in the care systems. The disinfecting or biocidal agents or their interaction 
with other components included in the formulation have been pointed as 
responsible for such reactions. 
Polyhexamethylene biguanide (PHMB) also known as polyhexanide, 
Dymed, polyhexidine and polyaminopropyl biguanide has been frequently 
related to solution induced corneal staining (SICS). However, the laboratory 
research was unable to establish an in vitro relationship with the in vivo 
clinical fi ndings. On the other hand, polyquaternium-1 also known, as 
Polyquad is other frequently used disinfecting agent also involved in such 
laboratory tests whose results are described in further detail below and will 
be summarized in Table 3.
A study from Santodomingo-Rubido et al. observed that different 
concentrations of certain ingredients commonly found in commercial CL 
solutions could be related with higher or lower citotoxicity of experimental 
cell lines from animal models (mouse lung cells) (Santodomingo-Rubido et 
al. 2006). Interestingly, the authors found that while some MPDS solutions 
were invariably associated to high or low levels of citotoxicity at any 
concentration between 1.25 to 10% of MPDS, the citotoxicity activity was 
largely dependent on concentration for other MPDS which was attributed 
to the biocidal agent included or to the combination of this agent with other 
ingredients such as buffer ingredients. Was also interesting to observe how 
certain surfactants such as Poloxamer 237 or Poloxamer 407 were invariably 
related to low and high citotoxicity irrespective of the concentration used, 
while citotoxicity of other surfactant Tetronic 1107 was dependent on 
concentration. Finally, cytotoxicity of most isotonic and buffer agents was 
found to be highly dependent on concentration (Santodomingo-Rubido et 
al. 2006). 
Other authors used to look at these issues in different ways using 
different laboratory assays. Chuang et al. used ApopTag Fluorescein 
Apoptosis assay to detect cell death after exposure to different MPDS, 
fl uorescein permeability to investigate the corneal epithelial barrier function 
and tight junction proteins zonula occludens (ZO)-1 and occludin were 
evaluated using immunofl uorescent staining (Chuang et al. 2008). Imayasu 
et al also evaluated the tight junction integrity of the corneal epithelial cells 
with ZO-1 (tight junction-related protein) labeling under laser confocal 
microscopy. 
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To investigate the changes of ultrastructure in tight junctions of human 
corneal epithelial cells, the same authors observed an ultrathin cross-section 
of the cell on collagen membrane using transmission electron microscopy. 
(Imayasu et al. 2008) Mowrey-McKee et al., evaluated citotoxicity of CL care 
systems using different modifi cations of the United States Pharmacopeia 
(USP) elution test required by U.S. Food and Drug Administration (FDA) 
and global standards organizations such as the International Standards 
Organization (ISO) for in vitro cytotoxicity testing of lens care solutions 
(Mowrey-McKee et al. 2002). Results of these and other evaluations 
are summarized in table 3. Despite all these studies found signifi cant 
differences between the citotoxicity of different MPS solutions, the different 
experimental conditions and techniques used limit the ability to compare 
and summarize the results from all these studies. Moreover, their results 
obtained “in vitro” did not relate much with the clinical observations such 
that, care systems reported as being safe in the clinical setting revealed 
worse behaviour in the laboratory assays and vice-versa.
Table 3 This table summarizes the results of different studies addressing the citotoxicity of 
several MPDS. 
* Currently not marketed.
Authors (year) Solutions evaluated Main outcomes
(Santodomingo-
Rubido et al. 2006)
Complete Moisture Plus*
MeniCare Soft
Opti-Free Express
ReNu Multiplus
Renu MoistureLoc*
SoloCare Aqua
Citotoxicity Activity (at medium 
concentration of 5%)
Complete < MeniCare < SoloCare 
< OptiFree < ReNu MultiPlus = 
ReNu MoistureLoc
(Chuang et al. 2008) Complete Easy Rub
OptiFree Express
OptiFree RepleniSH
ReNu Multiplus
Apoptosis Rates
Complete < ReNu < OptiFree 
RepleniSH < OptiFree Express
(Imayasu et al. 2008) MPS1: PHMB
MPS2: PHMB + Poloxamine + 
Boric Acid
MPS3: Alexidine + Poloxamine 
+ Boric Acid
MPS4: Polyquad + Poloxamine 
+ Boric Acid
Transepithelial Electrical Resistance 
Culture in Collagen Membrane 
(@120 min.)
MPS1 < MPS3 < MPS2 < MPS4
Combination of poloxamine and 
boric acid as potential cause of tigh 
junction damage
(Mowrey-McKee et 
al. 2002)
AOSept (neutral)
Complete Comfort Plus
OptiFree Express
ReNu
ReNu Multiplus
SoloCare Soft
Different Assays
Only OptiFree Express was 
considered citotoxic for trypan 
blue uptake test and cell regrowth 
(absent) following exposure to test 
material. ReNu products showed 
citotoxicity on quantifi cation of 
viable cells
Contact Lens Care Solutions and Ocular Surface 321
CHALLENGES FOR CURRENT MPDS DEVELOPMENT
After the outbreaks of MPDS-related infections during the last 5 years 
(Khor et al. 2006, Patel and Hammersmith 2008, Tu and Joslin 2010), there 
has been a great deal of discussion regarding the effi cacy of these systems 
and the suffi ciency of current FDA and ISO regulations regarding the tests 
that new systems must undergo for approval. 
This issue is aggravated by the known lack of compliance of many CL 
wearers with the correct guidelines of use of their CL and care systems. 
Such behaviours could eventually result in an increased risk for most of 
these wearers. Among some of the modifi able patient compliance-related 
behaviours, the following have been identifi ed as increased risk factors 
(relative risk, RR) for CL associated infections: inadequate hand-washing 
(RR=4.5 (Stapleton et al. 2007)), inadequate case cleaning (RR=4.0 (Houang 
et al. 2001)), failure to use correct disinfecting solution (RR=21.8 to 55.9; 
(Houang et al. 2001, Radford et al. 1998), failure to rub and rinse lenses 
(RR=3.5 (Radford et al. 1995)) and topping off solution (RR=2.5 (Saw et al. 
2007)), among others (Morgan et al. 2011). 
As a result, some new multipurpose and disinfecting solutions have 
been developed to meet criteria beyond the current regulatory standards. 
As such, new organisms as different strains of bacteria (i.e. metacilyn 
resistance Staphylococcus aureus also known as MRSA) or amoeba such as 
Acanthamoeba either in its trophozoite or cystic forms have became usual 
in the evaluation of biocidal activity of new care systems as previously 
described in this chapter (Kilvington et al. 2010; Zhu et al. 2007). 
ROLE OF CARE SOLUTIONS IN IMPROVING CL’s 
CLINICAL PERFORMANCE
When it comes to the relationship between adverse events in the ocular 
surface and the potential impact of MPS on their aetiology, it is hard to 
establish a direct relationship. However, it is commonly accepted that 
the interaction between some MPDS ingredients and the ocular surface, 
mediated or not thought particular interactions of those with the CL 
material, can have a negative impact in the tolerance of CL with the ocular 
surface (Andrasko et al. 2006, Carnt et al. 2007, Garofalo et al. 2005).
Nowadays, care systems no longer pretend only to perform well in 
terms of cleaning and disinfecting effi cacy but play also an important role 
in CL performance by improving physical comfort at insertion and through 
the whole period of wear.
Indeed, several studies pointed out the role of care systems in preventing 
or recovering from ocular surface damage related to CL as is the case of 
superfi cial punctuate corneal staining or SICS. SICS identifi cation required 
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that at least 4 out of 5 regions of the cornea are affected by this superfi cial 
staining (Fig. 2).
Current knowledge advocates for the role of care systems in reducing 
SICS events. Hydrogen peroxide has been proposed as an effective strategy 
in case of corneal staining potentially related to multipurpose solution 
(Carnt et al. 2007, Papas et al. 2007). Additionally, the pre-application of 
carboxymethylcellulose (CMC) lubricating and wetting drops (artifi cial 
tears) has demonstrated to signifi cantly reduce the incidence of corneal 
staining in conventional hydrogel CL (Coles et al. 2004) and silicone 
hydrogel soft CL wearers (Paugh et al. 2007). 
Figure 2 Typical appearance of a peripheral corneal staining covering 4 quadrants (superior 
one not seen in this photograph).
Color image of this figure appears in the color plate section at the end of the book.
Another fi eld of interest is the introduction of wetting agents and other 
active ingredients into new MPDS formulations to improve the hydration 
retention of CL materials and improve the long-term comfort. With this 
purpose, new solutions such as Biotrue (Bausch & Lomb) incorporate 
derivates of hyaluronic acid to make the lens material hydration to last and 
the company claims up to 20 hours of hyaluronan retention in the matrix 
of different hydrogel and silicone hydrogel CL with the potential benefi t of 
improved end-of-day comfort (Scheuer et al. 2010). An additional purpose 
of this formulation is to maintain native tear proteins in their natural state 
instead of denaturating onto the CL material, providing a chance to develop 
adverse reactions on the ocular surface (Barniak et al. 2010). Although the 
benefi ts of these new formulations on lens dehydration and whole day 
lens comfort will need to be further demonstrated by independent studies, 
the active implication of the CL care systems to improve CL comfort over 
time present as a promissory strategy to improve the whole CL wearing 
experience and eventually decrease the drop-out rate among CL wearers 
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as most of these discontinuations seem to be directly related with dryness 
and discomfort symptoms (Pritchard et al. 1999).
CONCLUSIONS
Finally, the modes in which care systems are used seem to be critical to 
improve their performance in several aspects. Although in the recent past 
MPDS use to include a non-rub claim, it has been proved that the inclusion 
of rub and rinse steps improves signifi cantly the performance of MPDS 
solutions in terms of disinfection effi cacy (Zhu et al. 2011). Rub and rinse 
step in addition to other compliance recommendations such as tissue-wipe 
and air-dry demonstrated to be very effective in eliminating microorganisms 
and biofi lms from CL storage cases (Wu et al. 2010, Wu et al. 2011). 
These strategies, in addition to the high antimicrobial effi cacy of 
modern MPDS formulations (some of them at the expense of including a 
double biocidal agent in their formulation) should render positive results 
in terms of reduced CL case contamination thus lowering the incidence of 
adverse events related to contact lens wear and their potential interaction 
with care systems. 
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